Warsaw-4-PhD is a doctoral school established through the collaboration of nine scientific institutes in Warsaw. The school educates doctoral candidates in four disciplines: biology, chemistry, physics, and medicine. It offers a modern educational programme based on individual research plans. Recruitment occurs several times a year for specific research projects submitted by the institutes co-creating the school.

Information about the School can be found on the website warsaw4phd.eu/szkola .

Prof. Dr. hab. n. med. Magdalena Kowalewska
Head of the Medicine Specialisation at the Warsaw-4-PhD Doctoral School:

Prof. Dr. hab. n. med. Magdalena Kowalewska

e-mail: Magdalena.Kowalewska@nio.gov.pl

CONTACT

MA / MSc Agnieszka Samborska

tel. 22 546 28 78
e-mail: Agnieszka.Samborska@nio.gov.pl

Recruitment for the Doctoral Student – Scholarship Holder Position

If you are interested in science and oncology, we invite you to apply on the Warsaw-4-PhD Doctoral School website: https://warsaw4phd.eu/dla-kandydatow/rekrutacja/

The online application process for candidates to the Doctoral School for the academic year 2026/2027 is open from 24 July 2026 (Friday) to 07 August 2026 (Friday).

We are looking for a candidate for a doctoral position in the Horizon Europe MSCA SPACE-MEL doctoral network.
The project description and candidate requirements can be found on the website:
https://warsaw4phd.eu/yleerdad/2026/07/Project-No.-7.1-Investigating-microenvironment-and-sub-clonal-heterogeneity-of-MuM-upon-progression-professor-Anna-Szumera-Cieckiewicz.pdf

Details →

Recruitment for the Doctoral Student – Scholarship Holder Position

If you are interested in science and oncology, we invite you to apply on the Warsaw-4-PhD Doctoral School website: https://warsaw4phd.eu/dla-kandydatow/rekrutacja/

The online application process for candidates to the Doctoral School for the academic year 2026/2027 is open from 18 May 2026 to 31 May 2026.

We are looking for a doctoral student to undertake a 4-year research project funded under the OPUS NCN grant.
The project description and candidate requirements can be found on the website:
Project 7.1 The impact of periostin (POSTN) on the stromal microenvironment and the development of the neuroendocrine phenotype in prostate cancer (Prof. Dr. hab. Michał Mikula / Dr. Hubert Pakuła)

Details →

List of research projects conducted within the Warsaw-4-PhD Doctoral School.

No.
Student
Title of Work
Organisational Unit
Project Leader
1
Mostafa Kianfar
Redefining cell death mechanisms via entosis; the role of HAX1 and SETP7 proteins in breast cancer models in vivo and in vitro
Department of Molecular and Translational Oncology
Prof. Dr. hab. n. med. Ewa Grzybowska
2
Klaudia Bobak
Molecular characterisation of response to neoadjuvant chemoradiotherapy in patients with locally advanced soft tissue sarcomas
Clinic of Soft Tissue, Bone and Melanoma Cancers
Prof. Dr. hab. n. med. Anna M. Czarnecka
3
Łukasz Taraszkiewicz
Improving the quality of archival data in the Polish Haemato-Oncological Registry (PROH) and epidemiological studies on haematological-oncological cancers in Polish adolescent and young adult patients diagnosed between 2000-2022
National Cancer Registry
Prof. Dr. hab. n. med. Joanna Didkowska
4
Maria Wypchło
The significance of steroidogenic factor 1 expression in somatotroph neuroendocrine pituitary tumours
Department of Molecular and Translational Oncology
Dr. hab. n. med. Mateusz Bujko
5
Marta Zaborowska
Assessment of the effectiveness of treatment for gastroenterological complications associated with immunotherapy – a retrospective study
Clinic of Oncological Gastroenterology
Prof. Dr. hab. n. med. Edyta Zagórowicz
6
Bahareh Mehrparvar
The role of metabolic disorders modulated by MTARC2 protein in colorectal cancer
Cancer Metabolism Laboratory
Prof. Dr. hab. n. med. Michał Mikula
7
Mritunjoy Dey
The role of microRNA in the pathobiology of chondrosarcomas
Clinic of Soft Tissue, Bone and Melanoma Cancers
Prof. Dr. hab. n. med. Anna M. Czarnecka
8
Aleksandra Wiśniewska
Analysis of immune response to neoadjuvant radiotherapy and immunotherapy in soft tissue sarcomas
Clinic of Soft Tissue, Bone and Melanoma Cancers
Prof. Dr. hab. n. med. Piotr Rutkowski
9
Izabela Agnieszczak
Evaluation of early-phase clinical trials as a therapeutic option for oncology patients
Department of Early Phase Clinical Trials
Dr. hab. n. med. Iwona Ługowska
10
Magda Krakowczyk
Ubiquitin as a modulator of protein transport to mitochondria
Cancer Metabolism Laboratory
Prof. Dr. hab. n. med. Michał Mikula / Dr. Piotr Brągoszewski
11
Krutika Thakkur
Ubiquitin as a modulator of protein transport to mitochondria
Cancer Metabolism Laboratory
Prof. Dr. hab. n. med. Michał Mikula / Dr. Piotr Brągoszewski